Cognex Corporation (NASDAQ: CGNX) today reported financial results for the second quarter of 2021. Cognex announced the highest quarterly revenue in the company’s 40-year history and new records for second quarter revenue, net income, and net income per diluted share. Table 1 below shows selected financial data for Q2-21 compared with Q2-20 and Q1-21, and for the six months of 2021 compared with the same period in 2020.
Table 1 | ||||
(Dollars in thousands, except per share amounts) | ||||
|
Revenue |
Net Income/(Loss) | Net Income/(Loss) per Diluted Share | Non-GAAP Net Income per Diluted Share* |
Quarterly Comparisons | ||||
Current quarter: Q2-21 | $269,158 | $77,598 | $0.43 | $0.43 |
Prior year’s quarter: Q2-20 | $169,097 | $(1,142) | $(0.01) | $0.18 |
Change: Q2-20 to Q2-21 | 59% | N/M | N/M | 139% |
Prior quarter: Q1-21 | $239,027 | $69,848 | $0.39 | $0.36 |
Change: Q1-21 to Q2-21 | 13% | 11% | 10% | 19% |
Year-to-Date Comparisons | ||||
Six months ended July 4, 2021 | $508,185 | $147,446 | $0.82 | $0.79 |
Six months ended June 28, 2020 | $336,332 | $19,335 | $0.11 | $0.29 |
Change from first six months of 2020 to first six months of 2021 | 51% | 663% | 645% | 172% |
*Non-GAAP net income per diluted share excludes restructuring and other charges and discrete tax adjustments. Notably, Cognex recorded charges totaling over $42 million in Q2-20 that reduced earnings for the quarter by $0.19 per diluted share. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.
“What a quarter!” said Robert J. Willett, Chief Executive Officer of Cognex. “Revenue was the highest in our company’s 40-year history and grew substantially year over year due to strong, broad-based demand for Cognex products. We were also highly profitable and reported an operating margin of 34%, which is well above our 30% long-term target.”
Mr. Willett continued, “We are excited about the growth opportunities we see for our company, and we are managing well so far through a difficult supply environment. Even so, we expect the revenue growth rate will moderate in the second half, particularly in Q3, because of the substantial increase in revenue we reported last year from the consumer electronics industry.”
Details of the Quarter
Statement of Operations Highlights – Second Quarter of 2021
Balance Sheet Highlights – July 4, 2021
Financial Outlook – Q3 2021
Non-GAAP Financial Measures
Analyst Conference Call and Simultaneous Webcast
About Cognex Corporation
Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.
Cognex is the world's leader in the machine vision industry, having shipped more than 3 million image-based products, representing over $8 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.
Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements—which include statements regarding business and market trends; future financial performance; growth opportunities; the expected impact of the COVID-19 pandemic on our assets, business and results of operations; managing supply constraints; customer order rates and timing of related revenue; future product mix; restructuring and other cost-savings initiatives; research and development activities; sales and marketing activities; investments; liquidity; dividends and stock repurchases; strategic plans; and estimated tax benefits and expenses and other tax matters—involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the impact, duration, and severity of the COVID-19 pandemic; (2) potential disruptions to our business due to restructuring activities; (3) the loss of, or curtailment of purchases by, large customers in the consumer electronics and logistics industries; (4) the reliance on revenue from the automotive industry; (5) the reliance on key suppliers to manufacture and deliver critical components for our products and potential disruptions in the supply chain, which could impact timely delivery of customer orders; (6) the failure to effectively manage product transitions or accurately forecast customer demand; (7) the inability to design and manufacture high-quality products; (8) the inability to attract and retain skilled employees and maintain our unique corporate culture; (9) the failure to effectively manage our growth; (10) the inability to achieve growth in revenue and profits from the logistics industry; (11) the technological obsolescence of current products and the inability to develop new products; (12) the failure to properly manage the distribution of products and services; (13) the impact of competitive pressures; (14) the challenges in integrating and achieving expected results from acquired businesses; (15) potential disruptions in our business systems; (16) information security breaches; (17) the inability to protect our proprietary technology and intellectual property; (18) potential impairment charges with respect to our investments or acquired intangible assets; (19) exposure to additional tax liabilities; (20) fluctuations in foreign currency exchange rates and the use of derivative instruments; (21) our involvement in time-consuming and costly litigation; (22) unfavorable global economic conditions; (23) economic, political, and other risks associated with international sales and operations; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2020 and Form 10-Q for the fiscal quarter ended July 4, 2021. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.
Exhibit 1
COGNEX CORPORATION | ||||||||||||||||||||
Statements of Operations | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
Dollars in thousands, except per share amounts | ||||||||||||||||||||
| Three-months Ended |
| Six-months Ended | |||||||||||||||||
| July 4, |
| April 4, |
| June 28, |
| July 4, |
| June 28, | |||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Revenue | $ | 269,158 |
|
| $ | 239,027 |
|
| $ | 169,097 |
|
| $ | 508,185 |
|
| $ | 336,332 |
| |
Cost of revenue (1) | 68,432 |
|
| 54,045 |
|
| 50,320 |
|
| 122,477 |
|
| 91,520 |
| ||||||
Gross margin | 200,726 |
|
| 184,982 |
|
| 118,777 |
|
| 385,708 |
|
| 244,812 |
| ||||||
Percentage of revenue | 75 | % |
| 77 | % |
| 70 | % |
| 76 | % |
| 73 | % | ||||||
Research, development, and engineering expenses (1) | 31,302 |
|
| 34,105 |
|
| 30,397 |
|
| 65,407 |
|
| 66,343 |
| ||||||
Percentage of revenue | 12 | % |
| 14 | % |
| 18 | % |
| 13 | % |
| 20 | % | ||||||
Selling, general, and administrative expenses (1) | 76,843 |
|
| 72,424 |
|
| 60,153 |
|
| 149,267 |
|
| 129,291 |
| ||||||
Percentage of revenue | 29 | % |
| 30 | % |
| 36 | % |
| 29 | % |
| 38 | % | ||||||
Restructuring charges | — |
|
| — |
|
| 14,798 |
|
| — |
|
| 14,798 |
| ||||||
Intangible asset impairment charges | — |
|
| — |
|
| 19,571 |
|
| — |
|
| 19,571 |
| ||||||
Operating income (loss) | 92,581 |
|
| 78,453 |
|
| (6,142 | ) |
| 171,034 |
|
| 14,809 |
| ||||||
Percentage of revenue | 34 | % |
| 33 | % |
| (4 | )% |
| 34 | % |
| 4 | % | ||||||
Foreign currency gain (loss) | (639 | ) |
| (1,008 | ) |
| 336 |
|
| (1,647 | ) |
| (2,667 | ) | ||||||
Investment and other income | 1,596 |
|
| 1,386 |
|
| 3,494 |
|
| 2,982 |
|
| 8,540 |
| ||||||
Income (loss) before income tax expense (benefit) | 93,538 |
|
| 78,831 |
|
| (2,312 | ) |
| 172,369 |
|
| 20,682 |
| ||||||
Income tax expense (benefit) | 15,940 |
|
| 8,983 |
|
| (1,170 | ) |
| 24,923 |
|
| 1,347 |
| ||||||
Net income (loss) | $ | 77,598 |
|
| $ | 69,848 |
|
| $ | (1,142 | ) |
| $ | 147,446 |
|
| $ | 19,335 |
| |
Percentage of revenue | 29 | % |
| 29 | % |
| (1 | )% |
| 29 | % |
| 6 | % | ||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Net income (loss) per weighted-average common and common-equivalent share: |
|
|
|
|
|
|
|
|
| |||||||||||
Basic | $ | 0.44 |
|
| $ | 0.40 |
|
| $ | (0.01 | ) |
| $ | 0.84 |
|
| $ | 0.11 |
| |
Diluted | $ | 0.43 |
|
| $ | 0.39 |
|
| $ | (0.01 | ) |
| $ | 0.82 |
|
| $ | 0.11 |
| |
|
|
|
|
|
|
|
|
|
| |||||||||||
Weighted-average common and common-equivalent shares outstanding: |
|
|
|
|
|
|
|
|
| |||||||||||
Basic | 176,626 |
|
| 176,288 |
|
| 172,283 |
|
| 176,454 |
|
| 172,345 |
| ||||||
Diluted | 179,991 |
|
| 179,971 |
|
| 172,283 |
|
| 179,982 |
|
| 175,499 |
| ||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Cash dividends per common share | $ | 0.060 |
|
| $ | 0.060 |
|
| $ | 0.055 |
|
| $ | 0.120 |
|
| $ | 0.110 |
| |
Cash and investments per common share | $ | 5.39 |
|
| $ | 4.96 |
|
| $ | 5.18 |
|
| $ | 5.39 |
|
| $ | 5.18 |
| |
Book value per common share | $ | 8.09 |
|
| $ | 7.68 |
|
| $ | 7.95 |
|
| $ | 8.09 |
|
| $ | 7.95 |
| |
|
|
|
|
|
|
|
|
|
| |||||||||||
(1) Amounts include stock-based compensation expense, as follows: |
|
|
|
|
|
|
|
|
| |||||||||||
Cost of revenue | $ | 351 |
|
| $ | 248 |
|
| $ | 363 |
|
| $ | 599 |
|
| $ | 717 |
| |
Research, development, and engineering | 3,064 |
|
| 4,003 |
|
| 2,401 |
|
| 7,067 |
|
| 7,767 |
| ||||||
Selling, general, and administrative | 7,315 |
|
| 7,758 |
|
| 5,254 |
|
| 15,073 |
|
| 14,324 |
| ||||||
Total stock-based compensation expense | $ | 10,730 |
|
| $ | 12,009 |
|
| $ | 8,018 |
|
| $ | 22,739 |
|
| $ | 22,808 |
| |
Exhibit 2
COGNEX CORPORATION | |||||||||||||||||||||
Reconciliation of Selected Items from GAAP to Non-GAAP | |||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
Dollars in thousands, except per share amounts | |||||||||||||||||||||
| Three-months Ended |
|
| Six-months Ended | |||||||||||||||||
| July 4, |
| April 4, |
| June 28, |
|
| July 4, |
| June 28, | |||||||||||
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Discrete tax adjustments reconciliation |
|
|
|
|
|
|
| ||||||||||||||
Income (loss) before income tax expense (benefit) (GAAP) | $ | 93,538 |
|
| $ | 78,831 |
|
| $ | (2,312 | ) |
|
| $ | 172,369 |
|
| $ | 20,682 |
| |
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Income tax expense (benefit) (GAAP) | $ | 15,940 |
|
| $ | 8,983 |
|
| $ | (1,170 | ) |
|
| $ | 24,923 |
|
| $ | 1,347 |
| |
Effective tax rate (GAAP) | 17 | % |
| 11 | % |
| (51 | )% |
|
| 14 | % |
| 7 | % | ||||||
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Discrete tax benefit related to stock-based compensation | 1,431 |
|
| 5,207 |
|
| 4,413 |
|
|
| 6,638 |
|
| 6,093 |
| ||||||
Discrete tax expense related to tax return filings and other | (535 | ) |
| — |
|
| (3,267 | ) |
|
| (535 | ) |
| (3,509 | ) | ||||||
Total discrete tax adjustments | $ | 896 |
|
| $ | 5,207 |
|
| $ | 1,146 |
|
|
| $ | 6,103 |
|
| $ | 2,584 |
| |
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Income tax expense (benefit) (Non-GAAP) | $ | 16,836 |
|
| $ | 14,190 |
|
| $ | (24 | ) |
|
| $ | 31,026 |
|
| $ | 3,931 |
| |
Effective tax rate (Non-GAAP) | 18 | % |
| 18 | % |
| (1 | )% |
|
| 18 | % |
| 19 | % | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Restructuring and other charges and discrete tax adjustments reconciliation |
|
|
|
|
|
|
| ||||||||||||||
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Net income (loss) (GAAP) | $ | 77,598 |
|
| $ | 69,848 |
|
| $ | (1,142 | ) |
|
| $ | 147,446 |
|
| $ | 19,335 |
| |
Excess and obsolete inventory charges | 1,111 |
|
| 705 |
|
| 7,718 |
|
|
| 1,816 |
|
| 8,783 |
| ||||||
Restructuring charges | — |
|
| — |
|
| 14,798 |
|
|
| — |
|
| 14,798 |
| ||||||
Intangible asset impairment charges | — |
|
| — |
|
| 19,571 |
|
|
| — |
|
| 19,571 |
| ||||||
Tax effect on restructuring and other charges | (200 | ) |
| (127 | ) |
| (7,997 | ) |
|
| (327 | ) |
| (8,199 | ) | ||||||
Discrete tax adjustments | (896 | ) |
| (5,207 | ) |
| (1,146 | ) |
|
| (6,103 | ) |
| (2,584 | ) | ||||||
Net income (Non-GAAP) | $ | 77,613 |
|
| $ | 65,219 |
|
| $ | 31,802 |
|
|
| $ | 142,832 |
|
| $ | 51,704 |
| |
Percentage of revenue (Non-GAAP) | 29 | % |
| 27 | % |
| 19 | % |
|
| 28 | % |
| 15 | % | ||||||
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP) | $ | 0.43 |
|
| $ | 0.39 |
|
| $ | (0.01 | ) |
|
| $ | 0.82 |
|
| $ | 0.11 |
| |
Per share impact of non-GAAP adjustments identified above | — |
|
| (0.03 | ) |
| 0.19 |
|
|
| (0.03 | ) |
| 0.18 |
| ||||||
Net income per diluted weighted-average common and common-equivalent share (Non-GAAP) | $ | 0.43 |
|
| $ | 0.36 |
|
| $ | 0.18 |
|
|
| $ | 0.79 |
|
| $ | 0.29 |
| |
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP) | 179,991 |
|
| 179,971 |
|
| 175,403 |
|
|
| 179,982 |
|
| 175,499 |
| ||||||
|
|
|
|
|
|
|
|
|
|
| |||||||||||
|
|
|
|
|
|
|
|
|
|
|
Exhibit 3
COGNEX CORPORATION | ||||||||
Balance Sheets | ||||||||
(Unaudited) | ||||||||
Dollars in thousands | ||||||||
| July 4, 2021 |
| December 31, 2020 | |||||
Assets |
|
|
| |||||
Cash and investments | $ | 951,749 |
|
| $ | 767,438 |
| |
Accounts receivable | 149,157 |
|
| 125,696 |
| |||
Inventories | 68,503 |
|
| 60,830 |
| |||
Property, plant, and equipment | 76,972 |
|
| 79,173 |
| |||
Operating lease assets | 21,277 |
|
| 22,582 |
| |||
Goodwill and intangible assets | 256,608 |
|
| 259,633 |
| |||
Deferred tax assets | 425,618 |
|
| 434,704 |
| |||
Other assets | 75,037 |
|
| 50,646 |
| |||
|
|
|
| |||||
Total assets | $ | 2,024,921 |
|
| $ | 1,800,702 |
| |
|
|
|
| |||||
Liabilities and Shareholders' Equity |
|
|
| |||||
Accounts payable and accrued expenses | $ | 108,957 |
|
| $ | 93,534 |
| |
Deferred revenue and customer deposits | 76,445 |
|
| 21,274 |
| |||
Operating lease liabilities | 24,250 |
|
| 26,230 |
| |||
Income taxes | 67,834 |
|
| 72,551 |
| |||
Deferred tax liabilities | 306,355 |
|
| 314,952 |
| |||
Other liabilities | 11,626 |
|
| 9,959 |
| |||
Shareholders' equity | 1,429,454 |
|
| 1,262,202 |
| |||
|
|
|
| |||||
Total liabilities and shareholders' equity | $ | 2,024,921 |
|
| $ | 1,800,702 |
|
Last Trade: | US$36.25 |
Daily Change: | 0.55 1.54 |
Daily Volume: | 634,224 |
Market Cap: | US$6.220B |
October 30, 2024 July 31, 2024 May 02, 2024 |
UGE International develops, owns, and operates commercial and community solar projects in the United States and strategic markets abroad. Our distributed energy solutions deliver cheaper, cleaner energy to businesses and consumers...
CLICK TO LEARN MOREElse Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS